SecBot SecBot

JANL

JANEL CORP
OTC· Services-Business Services, NEC· Inc. NV· CIK 0001133062 Software & IT
$48.00 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $48.00
1 year
+33.3%
from $36.01 · Oct 28
30 days
0.0%
from $48.00
52-week range
$30.50–58.00
−17% from high · low Nov 25
Avg volume 20D
210
Oct 15 spike 2.2K
Short interest
33
−73.2%
Days to cover
1.0
at average volume
Insider net
+$111.4K
1 buyer · 0 sellers · 12 mo
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest NEUTRAL Janel Corp, through its wholly owned subsidiary Antibodies Incorporated, acquired 100% of EnCor…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • B May 13 to May 14 2 days of insider buys: $22.7K by 1 insider, avg $47.78
  • B May 28 to Jun 2 2 days of insider buys: $49.1K by 1 insider, avg $43.69
  • X Aug 14 Short interest jumps 62.4% to 138
  • B Sep 9 to Sep 14 3 days of insider buys: $39.6K by 1 insider, avg $49.76
  • X Sep 15 Short interest falls 26.8% to 123
  • X Sep 30 Short interest falls 73.2% to 33

Signal stack

Where each data set points today.

  • InsidersBULLISH

    1 insider bought $111.4K at an average $46.52. No open-market sales.

  • Short sellersCOVERING

    Short interest −73.2% to 33 shares. 1.0 days to cover.

  • TrendDOWNTREND

    4% below its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 22, 2026 SEC
Janel Corp, through its wholly owned subsidiary Antibodies Incorporated, acquired 100% of EnCor Biotechnology Inc. for…
8-K — Impact 5/10
Oct 1, 2026 Insider
GRAVES GREGORY B was granted 2,500 shares
Director
Oct 1, 2026 Insider
MELSEN GREGORY J was granted 2,500 shares
Director
Oct 1, 2026 Insider
van Kesteren Gerard was granted 2,500 shares
Director
Jul 30, 2026 Earnings calendar
JANL Q3 2026 Earnings Scheduled — 2026-07-30
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Jul 30, 2026
Earnings date
JANL Q3 2026 Earnings Scheduled — 2026-07-30
May 7, 2026
Earnings date
JANL Q2 2026 Earnings Scheduled — 2026-05-07

Insider ledger

Form 4
$111.4K
bought · 1 insider
$0
sold · 0 insiders
+3.2%
vs their $46.52 cost
DateInsiderTypeValue
Oct 1, 2026
GRAVES GREGORY B
Director
AWARD2,500 sh
Oct 1, 2026
MELSEN GREGORY J
Director
AWARD2,500 sh
Oct 1, 2026
van Kesteren Gerard
Director
AWARD2,500 sh
Oct 1, 2026
Gonzalez John Joseph II
Director
AWARD2,500 sh
Oct 1, 2026
Miller Ryan Karen
Director
AWARD2,500 sh
Sep 14, 2026
GRAVES GREGORY B
Director
BUY$15.0K
Sep 11, 2026
GRAVES GREGORY B
Director
BUY$4.6K
Sep 9, 2026
GRAVES GREGORY B
Director
BUY$20.0K

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
33
shares short
-73.2%
vs prior settlement
1.0
days to cover

SecBot reports

1 filing · 0 bullish · 0 bearish · 1 neutral
All JANL filing & press-release reports (1)